Enavate Sciences GP, LLC - 09 Mar 2026 SCHEDULE 13D/A Report for CAMP4 THERAPEUTICS CORPORATION Common Stock, $0.0001 par value per share (CAMP)
- Filing Manager
- Enavate Sciences GP, LLC
- Reporting Manager
- Enavate Sciences GP, LLC
- Symbol
- CAMP
- Shares outstanding
- 51,990,875 shares
- Disclosed Ownership
- 2,495,562 shares
- Ownership
- 4.8%
- Form type
- SCHEDULE 13D/A
- Filing time
- 11 Mar 2026, 17:57:20 UTC
- Date of event
- 09 Mar 2026
- Previous filing
- 23 Dec 2025
- SEC
- View on sec.gov
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Enavate Sciences GP, LLC | 4.8% | 2,495,562 | 0 | 2,495,562 | /s/ James P. Boylan | By James P. Boylan, Manager | 0001953107 |
| Everest Aggregator, LP | 4.8% | 2,495,562 | 0 | 2,495,562 | /s/ James P. Boylan | By: Enavate Sciences GP, LLC, its General Partner, By James P. Boylan, Manager | 0002040426 |